Biotecnol is a private biopharmaceutical company working in the field of immuno-oncology. Biotecnol uses its proprietary antibody-based technologies to engineer and develop highly-targeted therapeutic products which utilize a patient’s own immune system to fight highly aggressive subtypes of oncological diseases, where standard of care treatments have shown little benefit